Restricted Access

Before you enter

All products are sold strictly for in-vitro laboratory research — not for human consumption, therapeutic, or veterinary use.

Your confirmation is saved for 7 days. You will only be asked to confirm once per week.
By entering you accept full responsibility for compliance with all applicable laws.

For research use only  ·  Not for human or animal consumption
Home/Products/Melanotan II
Melanotan II research vial Third-party tested
Melanocortin Peptide

Melanotan II

MT-II
MT-2Melanotan 2 CAS 121062-08-6

A cyclic melanocortin peptide analog of α-MSH, studied at melanocortin receptors (MC1R–MC5R) in laboratory models.

$30.00$3.00 / mg
Strength

Availability: 9 in stock

Fast U.S. shippingFree on orders over $200
Third-party testedIndependent lab, every batch
Purity documentedHPLC + mass spec
Secure checkoutVenmo · Cash App · Zelle
01Research snapshot

Melanotan II, by the numbers.

Structural and laboratory facts that define this compound. For laboratory research use only.

0
Amino acid residues

Cyclic heptapeptide core

0
Molecular weight

g/mol · C50H69N15O9

0
Receptor subtypes

MC1R – MC5R melanocortin family

0
Lactam bridge

Asp–Lys cyclization

02Molecular structure

The Melanotan II molecule

A schematic atomic representation shown next to the compound's molecular data. The figure is illustrative, not a measured conformation.

CHNOS
Molecular formula
C50H69N15O9
Mol. weight1024.2 g/mol
Sequence length7 residues
CAS121062-08-6
Physical formLyophilized powder
Purity99%+ HPLC
Use classResearch only
Ac-NleAspHisD-PheArgTrpLys-NH2
03Mechanism of action

How it is studied.

Non-selective melanocortin receptor agonism studied across pigmentation, metabolic, and sexual function research

01
MC1R Agonism Melanocyte Stimulation & Pigmentation

Melanotan II (MTII) activates MC1R on melanocytes, stimulating intracellular cAMP production that drives melanogenesis — the synthesis of eumelanin (brown-black) pigment. This mechanism has been extensively studied as a model for understanding UV-independent tanning and photoprotective pigmentation pathways.

  • Potent MC1R agonism drives eumelanin synthesis
  • Activates adenylyl cyclase/cAMP/PKA signaling cascade
  • Increases melanin production without UV exposure in models
02
MC4R Agonism Central Appetite & Arousal Pathways

MTII's high-affinity binding at MC4R in the hypothalamus modulates both appetite suppression and arousal-related signaling. MC4R knockout studies demonstrate these pathways are distinct. MTII's non-selective binding at MC3R and MC4R makes it a pharmacological tool for dissecting melanocortin circuit functions in energy balance research.

  • MC4R activation suppresses food intake in animal models
  • Modulates hypothalamic energy expenditure circuits
  • Precursor to the more selective PT-141 (bremelanotide)
03
Receptor Selectivity Non-Selective Pan-MC Agonism

Unlike its derivative PT-141, Melanotan II is a non-selective melanocortin receptor agonist that activates MC1R through MC5R with varying affinities. This broad receptor activity makes it uniquely valuable as a pharmacological probe for studying the full melanocortin system in preclinical research, while also contributing to its broader side-effect profile.

  • Binds MC1R, MC3R, MC4R, and MC5R
  • ~1000× more potent than endogenous α-MSH at MC receptors
  • Cyclic D-Phe substitution confers metabolic resistance

Research pathway map

The primary pathways Melanotan II is investigated against in laboratory models.

Melanotan IITARGETS01MC1R Agonism02MC4R Agonism03Receptor Selectivity
Illustrative schematic based on published in-vitro and preclinical observations. Research use only.
04Specifications

Compound details.

Chemical nameMelanotan II (MT-II)
SynonymsMT-II, MT-2, Melanotan 2
SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
FormulaC50H69N15O9
Molecular weight1024.2 g/mol
CAS number121062-08-6
FormLyophilized powder
DocumentationThird-party COA, per batch

Storage & handling

Supplied as a lyophilized powder. Store the sealed vial refrigerated at 2–8°C, protected from light and moisture; −20°C for long-term storage. Keep reconstituted material refrigerated.

FOR RESEARCH USE ONLYNot for human or animal consumption. Intended strictly for qualified researchers performing in-vitro or analytical laboratory work. No medical, diagnostic or therapeutic claims are made.
J Am Chem Soc · 1989Design of a new class of superpotent cyclic alpha-melanotropins based on quenched dynamic simulations

Original design of the cyclic melanotropin series.

Al-Obeidi F et al., 1989 · PubMed ↗
Life Sci · 1996Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

Early pharmacology study.

Dorr RT et al., 1996 · PubMed ↗
Peptides · 2006Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization

Review of melanocortin peptide research.

Hadley ME, Dorr RT, 2006 · PubMed ↗
0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Scroll to Top